Bayer vs Hitachi: Founders, CEOs and History
Bayer was founded in 1863 by Friedrich Bayer, Johann Friedrich Weskott and is led by Bill Anderson. Hitachi was founded in 1910 by Namihei Odaira and is led by Toshiaki Tokunaga.
Company facts
Founders
Bayer
Friedrich Bayer
Bayer was founded in 1863 in Barmen, now part of Wuppertal, Germany, by two men with complementary skills: Friedrich Bayer, a dye merchant, and Johann Friedrich Weskott, a master dyer.
Johann Friedrich Weskott
Johann Friedrich Weskott was a German master dyer who co-founded what became Bayer. In 1863 he and his friend Friedrich Bayer, a dye salesman, formed Friedr. Bayer et comp. in Barmen, now part of Wuppertal, Germany.
Hitachi
Namihei Odaira
Hitachi possesses a historic, foundational founding story, rooted in the industrialization of early 20th-century Japan and driven by a nationalist obsession with technological independence.
CEOs and their tenures
Bayer
- Werner Wenning2002–2010
Chief Executive Officer and Chairman of the Board of Management
Wenning led Bayer from April 2002 to September 30, 2010. He took over months after the worldwide withdrawal of the cholesterol drug Baycol and spent his early years settling the claims that followed.
Source - Marijn Dekkers2010–2016
Chief Executive Officer and Chairman of the Board of Management
Dekkers was CEO from October 1, 2010 to April 30, 2016 and the first Bayer chief executive hired from outside the company. He narrowed Bayer to life sciences: in 2014 Bayer bought the consumer care business of Merck and Co.
Source - Werner Baumann2016–2023
Chief Executive Officer and Chairman of the Board of Management
Baumann became CEO in May 2016 and retired at the end of May 2023 after 35 years at Bayer. His defining decision was the acquisition of Monsanto, completed on June 7, 2018 at USD 128 per share, about USD 63 billion in total.
Source - Bill Anderson2023–present
Chief Executive Officer and Chairman of the Board of Management
Anderson, a chemical engineer who previously ran Roche's pharmaceuticals division and Genentech, joined Bayer's Board of Management on April 1, 2023 and became CEO on June 1, 2023.
Source
Hitachi
- Toshiaki Higashihara2016–2022
Former President and Chief Executive Officer
Shifted Hitachi from a sprawling conglomerate toward infrastructure and digital businesses.
Source - Keiji Kojima2022–2025
Executive Chairman (CEO 2022-2025)
Finished much of the portfolio cleanup and handed over a more focused group to Tokunaga.
Source - Toshiaki Tokunaga2025–present
President and Chief Executive Officer
Brings an energy and rail background to the top job as Hitachi Energy and Hitachi Rail drive more of the group's growth.
Source
Timeline: Bayer and Hitachi side by side
1863Bayer
Bayer Founded in Barmen, Germany
Friedrich Bayer and Johann Friedrich Weskott entered Friedrich Bayer et. Compagnie into the commercial register in Barmen, Germany, on August 1, 1863, to make synthetic fuchsine and aniline dyes for the textile industry using the new coal-tar chemistry.
1898Bayer
Heroin Marketed as a Cough Suppressant
Bayer began selling diacetylmorphine under the trademark Heroin as a cough suppressant and a supposedly non-addictive substitute for morphine. It stayed in Bayer's range until after World War I, long after its addictiveness was understood.
1899Bayer
Aspirin Registered as a Trademark
The Bayer chemist Felix Hoffmann had synthesized acetylsalicylic acid in a stable, pure form in 1897, and Bayer registered the trademark Aspirin on March 6, 1899. It became the first mass-market synthetic medicine and is still one of the most widely used.
1903Bayer
Veronal Barbiturate Sleep Aid Launched
Bayer licensed diethylbarbituric acid from Emil Fischer and Joseph von Mering and sold it as Veronal, the first barbiturate sleep aid.
1910Hitachi
Founding and First Induction Motor
Namihei Odaira establishes the machinery repair shop that becomes Hitachi, and develops Japan's first 5-horsepower induction motor, establishing the foundation for the company's dominance in electrical engineering.
1912Bayer
Headquarters Moved to Leverkusen
Under Carl Duisberg, Bayer moved its main chemical plant and head office to Leverkusen on the Rhine, building one of the largest industrial chemical sites in Europe. Leverkusen is still the group headquarters.
1918Bayer
US Assets Confiscated During World War I
Bayer's US assets and trademarks, including the Aspirin trademark, were confiscated by the Alien Property Custodian and sold to Sterling Products. Bayer lost its largest export market and the right to its own name in North America for decades.
1925Bayer
Merger into IG Farben
Bayer merged with BASF, Hoechst, Agfa and other German chemical companies to form IG Farbenindustrie AG, then the largest chemical and pharmaceutical group in the world. IG Farben's role in the Nazi war effort led the Allies to dissolve it after World War II.
1932Bayer
Prontosil Discovered by Gerhard Domagk
Gerhard Domagk, leading a research team in the Bayer laboratories, developed Prontosil, the first sulfonamide antibacterial and the forerunner of modern antibiotics. He was awarded the Nobel Prize in Physiology or Medicine in 1939 for the work.
1932Hitachi
Expansion into Railway Technology
Hitachi begins manufacturing electric locomotives and rail signaling systems, establishing a deep, institutionalized relationship with the Japanese national railway network that would evolve into the modern Hitachi Rail division.
1951Bayer
Re-established After the IG Farben Dissolution
Bayer was reincorporated as Farbenfabriken Bayer AG in 1951 after the Allied dissolution of IG Farben and rebuilt as an independent chemical and pharmaceutical company during West Germany's post-war recovery.
1959Hitachi
Entry into Computing and Electronics
Hitachi develops its first electronic computer, the HITAC, marking the company's strategic entry into the information technology sector and laying the groundwork for its future digital systems business.
1994Bayer
US Bayer Trademark Rights Reclaimed
Bayer bought Sterling Winthrop's over-the-counter drug business from SmithKline Beecham for about USD 1 billion, recovering the US and Canadian rights to the Bayer name and the Bayer Cross confiscated in 1918, plus the Aspirin trademark in Canada.
2001Bayer
Baycol Withdrawn Worldwide
Bayer voluntarily withdrew its cholesterol drug Baycol, sold as Lipobay outside the United States, in August 2001 after cases of fatal rhabdomyolysis, particularly at higher doses and in combination with gemfibrozil.
2006Bayer
Schering AG Acquired for About EUR 17 Billion
Bayer acquired Schering AG of Berlin for about $19.2 billion (EUR 17 billion) after counter-bidding against a hostile approach from Merck KGaA, adding the Mirena contraceptive franchise, oncology assets and a European pharmaceutical sales force.
2014Bayer
Merck Consumer Care Acquired for USD 14.2 Billion
Bayer closed the purchase of the consumer care business of Merck and Co. on October 1, 2014 for USD 14.2 billion in cash, adding Claritin, Coppertone and Dr. Scholl's and making Bayer one of the largest non-prescription medicine companies in the world.
2015Bayer
Covestro Spin-off
Bayer listed its materials science division as Covestro through an IPO on the Frankfurt Stock Exchange, ending its presence in plastics and polymers and leaving a group focused on pharmaceuticals, consumer health and crop science.
2016Hitachi
Toshiaki Higashihara becomes CEO
Toshiaki Higashihara became CEO of Hitachi in 2016. Shifted Hitachi from a sprawling conglomerate toward infrastructure and digital businesses.
2018Bayer
Monsanto Acquisition Completed for About USD 63 Billion
Bayer completed the acquisition of Monsanto on June 7, 2018, paying USD 128 per share, about USD 63 billion in total, the largest foreign acquisition by a German company.
2020Bayer
USD 10.9 Billion Roundup Settlement
Bayer agreed to pay about USD 10.9 billion to settle roughly 113,000 Roundup claims while continuing to maintain that glyphosate does not cause cancer. The programme did not end the litigation and new claims kept arriving.
2020Hitachi
Acquisition of ABB's Power Grids Business
Hitachi executes the $11 billion acquisition of ABB's Power Grids business, renaming it Hitachi Energy and instantly establishing the company as the global leader in HVDC transmission and grid infrastructure.
2021Hitachi
Acquisition of GlobalLogic
The company acquires the global digital engineering firm GlobalLogic for $9.6 billion, instantly establishing Hitachi as a top-tier provider of advanced software and product design services for the automotive and telecommunications sectors.
2022Hitachi
Hitachi Construction Machinery Stake Sale
Hitachi sold a controlling stake in Hitachi Construction Machinery to Itochu and Japan Industrial Partners, part of its exit from cyclical listed subsidiaries.
2023Bayer
Bill Anderson Becomes CEO
Werner Baumann retired at the end of May 2023 after 35 years at Bayer. Bill Anderson, previously head of Roche's pharmaceuticals division and of Genentech, joined the Board of Management in April and became CEO on June 1, 2023.
2024Bayer
Dynamic Shared Ownership Rolled Out
Bayer began introducing the Dynamic Shared Ownership operating model, replacing layers of middle management with self-directed teams.
2024Hitachi
Acquired Thales Ground Transportation Systems
Hitachi acquired Thales Ground Transportation Systems. Hitachi Rail completed its ~$1.88 billion (EUR 1.66 billion) acquisition of Thales's Ground Transportation Systems business, its rail signalling division, expanding Hitachi Rail to 51 countries and shiftin…
2025Bayer
Nubeqa Approved in the US for Metastatic Castration-Sensitive Prostate Cancer
The FDA approved Nubeqa (darolutamide) in June 2025 for metastatic castration-sensitive prostate cancer, a third indication, followed by EU authorization in July 2025.
2025Hitachi
Toshiaki Tokunaga Becomes CEO
Toshiaki Tokunaga became President and CEO on April 1, 2025, succeeding Keiji Kojima, who became Executive Chairman.
2026Bayer
Supreme Court Preemption Ruling and Proposed USD 7.25 Billion Roundup Class Settlement
In February 2026 Monsanto proposed a US nationwide class settlement funded by declining annual payments of up to USD 7.25 billion over as long as 21 years, which received preliminary approval in March 2026.
2026Hitachi
Record Results and Home Appliance Sale
Hitachi reported record FY2025 profit in April 2026 and agreed to sell 80.1% of its home appliance business to Nojima for about $737 million (¥110 billion).
Acquisitions
Bayer
- Monsanto Company2018$63B
- Merck Consumer Care2014$14.2B
- Schering AG2006$21.2B
- Sterling Winthrop OTC Business1994$1B
Hitachi
- Thales Ground Transportation Systems2024Undisclosed
- GlobalLogic2021Undisclosed
- ABB Power Grids2020Undisclosed
Questions about Bayer vs Hitachi
Who is the CEO of Bayer AG and Hitachi, Ltd.?
Bayer AG is led by Bill Anderson and Hitachi, Ltd. is led by Toshiaki Tokunaga. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Bayer AG founded vs Hitachi, Ltd.?
Bayer AG was founded in 1863 — 47 years before Hitachi, Ltd., which was founded in 1910. Bayer AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Hitachi, Ltd..
How many employees does Bayer AG have compared to Hitachi, Ltd.?
Bayer AG employs approximately 88,078 people, while Hitachi, Ltd. employs approximately 287,901. Hitachi, Ltd. has the larger workforce at 287,901 employees, compared to Bayer AG's 88,078. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Bayer AG and Hitachi, Ltd. headquartered?
Bayer AG is headquartered in Germany and Hitachi, Ltd. is headquartered in Japan. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Bayer AG and Hitachi, Ltd.?
Bayer AG was founded by Friedrich Bayer, Johann Friedrich Weskott. Hitachi, Ltd. was founded by Namihei Odaira.
Which company has a longer operating history — Bayer AG or Hitachi, Ltd.?
Bayer AG has been operating for approximately 163 years, making it the more established of the two companies. Hitachi, Ltd. has been in operation for around 116 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Bayer vs Hitachi overview